It has been another busy week for Australia's top brokers. This has led to the release of a large number of broker notes.
Three broker buy ratings that you might want to know more about are summarised below. Here's why brokers think these ASX shares are in the buy zone:
Accent Group Ltd (ASX: AX1)
According to a note out of UBS, its analysts have commenced coverage on this footwear retailer's shares with a buy rating and $3.00 price target. The broker believes Accent is well-placed for growth post-COVID and sees opportunities for its margins to expand and its store network to grow in the coming years. The Accent share price is trading at $2.41 on Friday afternoon.
CSL Limited (ASX: CSL)
A note out of Morgans reveals that its analysts have retained their add rating and lifted their price target on this biotherapeutics giant's shares to $334.70. This follows news that the company is acquiring Vifor Pharma. Morgans doesn't believe this deal is a sign that CSL's core business' growth is coming to an end. Instead, the broker feels it is a complementary acquisition with a strong product portfolio that has growth opportunities. The CSL share price is fetching $273.31 on Friday.
Qantas Airways Limited (ASX: QAN)
Analysts at Citi have retained their buy rating but trimmed their price target on this airline operator's shares to $5.86. This follows the release of a trading update from Qantas earlier this week. Although it will be posting a big first half loss, Citi remains positive on Qantas and believes the risk/reward on offer is attractive. Particularly given how at these levels, the broker thinks the International recovery is not priced in. The Qantas share price is trading at $4.82 today.
